In this article, we will explore AKR1B10 in detail, a topic that has captured the attention and interest of many in recent times. From its impact on society to its relevance in different fields of study, AKR1B10 has been the subject of debate and discussion in a wide range of contexts. Through an exhaustive analysis, we will seek to delve deeper into the many facets of AKR1B10, offering a comprehensive perspective that allows the reader to better understand its importance and implications. From its origins to its possible future implications, this article will approach AKR1B10 from various perspectives to provide a complete and enriching overview of this fascinating topic.
Aldo-keto reductase family 1 member B10 is an enzyme that in humans is encoded by the AKR1B10gene.[5][6][7]
This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. It is highly expressed in adrenal gland, small intestine, and colon, and may play an important role in liver carcinogenesis.[7]
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Hyndman DJ, Flynn TG (August 1998). "Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1399 (2–3): 198–202. doi:10.1016/s0167-4781(98)00109-2. PMID9765596.
Petrovic MG, Peterlin B, Hawlina M, Petrovic D (2005). "Aldose reductase (AC)n gene polymorphism and susceptibility to diabetic retinopathy in Type 2 diabetes in Caucasians". Journal of Diabetes and Its Complications. 19 (2): 70–3. doi:10.1016/j.jdiacomp.2004.08.004. PMID15745835.
Kang ES, Kim HJ, Paek KS, Jang HS, Chang KC, Lee JH, et al. (May 2005). "Phorbol ester up-regulates aldose reductase expression in A549 cells: a potential role for aldose reductase in cell cycle modulation". Cellular and Molecular Life Sciences. 62 (10): 1146–55. doi:10.1007/s00018-005-5024-4. PMID15928807. S2CID13502923.
Lee YS, Paek KS, Kang ES, Jang HS, Kim HJ, Kang YJ, et al. (November 2005). "Involvement of nuclear factor kappaB in up-regulation of aldose reductase gene expression by 12-O-tetradecanoylphorbol-13-acetate in HeLa cells". The International Journal of Biochemistry & Cell Biology. 37 (11): 2297–309. doi:10.1016/j.biocel.2005.04.016. PMID15936242.
Hazemann I, Dauvergne MT, Blakeley MP, Meilleur F, Haertlein M, Van Dorsselaer A, et al. (October 2005). "High-resolution neutron protein crystallography with radically small crystal volumes: application of perdeuteration to human aldose reductase". Acta Crystallographica. Section D, Biological Crystallography. 61 (Pt 10): 1413–7. Bibcode:2005AcCrD..61.1413H. doi:10.1107/S0907444905024285. PMID16204895.